SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $VCYT–Veracyte Announces New Study in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer